Solasia goes to market
Solasia becomes Japan’s first public biotech in months and looks to China
After becoming the first Japanese biotech to go public in 18 months, Solasia Pharma K.K. (Tokyo:4597) plans to use the proceeds to prepare to launch its first products in China.
Solasia raised ¥3.6 billion ($32 million) through the sale of 19.4